Search Results - "glucagon"

Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese mice by Patrick J. Knerr, Stephanie A. Mowery, Jonathan D. Douros, Bhavesh Premdjee, Karina Rahr Hjøllund, Yantao He, Ann Maria Kruse Hansen, Anette K. Olsen, Diego Perez-Tilve, Richard D. DiMarchi, Brian Finan

Connect to this object online.

The economic side of an oral sugar lowering therapy intensification by glucagon-like peptidt-1 receptor agonists by S. K. Zyryanov, I. N. Dyakov

Connect to this object online.

Deletion of the glucagon receptor gene before and after experimental diabetes reveals differential protection from hyperglycemia by Belen Rivero-Gutierrez, April Haller, Jenna Holland, Emily Yates, Radha Khrisna, Kirk Habegger, Richard Dimarchi, David D'Alessio, Diego Perez-Tilve

Connect to this object online.

Effect of teduglutide, a glucagon-like peptide-2 analog, in eosinophilic enterocolitis: a case report by Shoko Ogawa, Ken-ichiro Konishi, Kiyoshi Tanaka, Hajime Takayasu, Yoshimasa Uematsu, Takashi Ito, Hiroyuki Takahashi, Yusuke Kumamoto

Connect to this object online.

L-cell Arntl is required for rhythmic glucagon-like peptide-1 secretion and maintenance of intestinal homeostasis by Sarah E. Martchenko, Alexandre Martchenko, Andrew D. Biancolin, Alison Waller, Patricia L. Brubaker

Connect to this object online.

The Impact of Glucagon-like Peptide 1 Receptor Agonists on Obstructive Sleep Apnoea: A Scoping Review by Khang Duy Ricky Le, Kelvin Le, Felicia Foo

Connect to this object online.

Antioxidant, Physicochemical, and Cellular Secretion of Glucagon-Like Peptide-1 Properties of Oat Bran Protein Hydrolysates by Mallory E. Walters, William G. Willmore, Apollinaire Tsopmo

Connect to this object online.

Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Diabetes and Non-Alcoholic Fatty Liver Disease-Current Evidence by Emir M. Muzurović MD, MM, Špela Volčanšek MD, Karin Zibar Tomšić MD, PhD, Andrej Janež MD, PhD, Dimitri P. Mikhailidis MD, Manfredi Rizzo MD, PhD, Christos S. Mantzoros MD

Connect to this object online.

Inhibition of prolyl hydroxylases increases hepatic insulin and decreases glucagon sensitivity by an HIF-2α-dependent mechanism by Matthew Riopel, Jae-Su Moon, Gautam K. Bandyopadhyay, Seohee You, Kevin Lam, Xiao Liu, Tatiana Kisseleva, David Brenner, Yun Sok Lee

Connect to this object online.

Neural regulation of hindlimb muscle contraction-induced glucagon-like peptide-1 and peptide YY secretion in rats by Shin-ya Ueda, Hidehiro Nakahara, Kou Manabe, Tadayoshi Miyamoto

Connect to this object online.

Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection by Erin D. Michos, George L. Bakris, Helena W. Rodbard, Katherine R. Tuttle

Connect to this object online.

Healthcare professionals' perceptions and management of obesity & knowledge of glucagon, GLP‐1, GIP receptor agonists, and dual agonists by W. Timothy Garvey, Cathy D. Mahle, Trevor Bell, Robert F. Kushner

Connect to this object online.

The therapeutic potential of glucagon-like peptide-1 for persons with addictions based on findings from preclinical and clinical studies by Elisabet Jerlhag

Connect to this object online.

An Emerging Role of Glucagon-Like Peptide-1 in Preventing Advanced-Glycation-End-Product-Mediated Damages in Diabetes by Alessandra Puddu, François Mach, Alessio Nencioni, Giorgio Luciano Viviani, Fabrizio Montecucco

Connect to this object online.

A Cre-driver rat model for anatomical and functional analysis of glucagon (Gcg)-expressing cells in the brain and periphery by Huiyuan Zheng, Lorena López-Ferreras, Jean-Phillipe Krieger, Stephen Fasul, Valentina Cea Salazar, Natalia Valderrama Pena, Karolina P. Skibicka, Linda Rinaman

Connect to this object online.

Glucagon-like peptide-1 receptor agonists: new strategies and therapeutic targets to treat atherosclerotic cardiovascular disease by Tianyu Wang, Juncan Ding, Xinyi Cheng, Qiang Yang, Pengfei Hu

Connect to this object online.

A Comprehensive Review on Weight Gain following Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists for Obesity by Ibrahim Abdullah bin Ahmed

Connect to this object online.

GPR142 prompts glucagon-like Peptide-1 release from islets to improve β cell function by Hua V. Lin, Jingru Wang, Jie Wang, Weiji Li, Xuesong Wang, James T. Alston, Melissa K. Thomas, Daniel A. Briere, Samreen K. Syed, Alexander M. Efanov

Connect to this object online.

The Role of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in Diabetes-Related Neurodegenerative Diseases by Cheng D, Yang S, Zhao X, Wang G

Connect to this object online.

Clinical Impact of Semaglutide, a Glucagon-Like Peptide-1 Receptor Agonist, on Obesity Management: A Review by Alorfi NM, Algarni AS

Connect to this object online.